SCHEMBL30829495

SCHEMBL30829495

CCCn1nccc1C(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 1/20 0.46
▸ PLAU P00749 1/20 0.46
▸ KLKB1 P03952 1/20 0.46
▸ ELANE P08246 1/20 0.46
▸ FLT1 P17948 2/20 0.44
▸ KDR P35968 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ RAB9A P51151 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ NR3C2 P08235 1/20 0.42
▸ KMT2A Q03164 5/20 0.41
▸ MEN1 O00255 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6258525 0.90 F2 (0.43) F2PLAUKLKB1ELANEFLT1
SCHEMBL24937400 0.86 L3MBTL1 (0.56) F2PLAUKLKB1ELANEFLT1
SCHEMBL19436553 0.85 ALDH1A1 (0.47) FLT1KDRRAB9ANPC1NR3C2
SCHEMBL24875516 0.85 F2 (0.44) F2PLAUKLKB1ELANEFLT1
SCHEMBL20156357 0.84 MAPK1 (0.44) F2PLAUKLKB1ELANEFLT1
SCHEMBL7056155 0.83 F2 (0.48) F2PLAUKLKB1ELANEFLT1
SCHEMBL7056151 0.83 F2 (0.48) F2PLAUKLKB1ELANEFLT1
SCHEMBL31646349 0.83 F2 (0.43) F2PLAUKLKB1ELANEFLT1
SCHEMBL17438056 0.83 FLT1 (0.43) F2PLAUKLKB1ELANEFLT1
SCHEMBL31460083 0.81 F2 (0.47) F2PLAUKLKB1ELANEFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110603254-B Substituted pyrazole compounds and methods of using the same for treating hyperproliferative diseases 班塔姆制药有限责任公司 2024-04-12 — — CN disclosed
Send feedback